Trademark: HCODE 2239733
Word
HCODE
ID
2239733
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
19 November 2021
Registration Date
19 November 2021
Cancellation Date
28 July 2023
Owner(s)
Service
Goods and Services:
Class 42:
Providing online non-downloadable software for managing, administering, and monitoring of medication adherence; providing online non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SASS) services, namely, hosting software that enables health care providers, clinical trial personnel, and clinical trial sponsors to administer medication adherence programs, monitor patient behavior, and enable remote patient engagement providing online non-downloadable open source software for measuring patient behavior; platform as a service (PAAS) featuring artificial intelligence for use in drug development and analysis; platform as a service (PAAS) featuring artificial intelligence for use in performing analysis of medical and pharmaceutical data and providing insights into that data; platform as a service (PAAS) featuring artificial intelligence for use in computer vision model development; platform as a service (PAAS) featuring artificial intelligence for self-service data analysis processing in the field of medicine and pharmacology.
Providing online non-downloadable software for managing, administering, and monitoring of medication adherence; providing online non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SASS) services, namely, hosting software that enables health care providers, clinical trial personnel, and clinical trial sponsors to administer medication adherence programs, monitor patient behavior, and enable remote patient engagement providing online non-downloadable open source software for measuring patient behavior; platform as a service (PAAS) featuring artificial intelligence for use in drug development and analysis; platform as a service (PAAS) featuring artificial intelligence for use in performing analysis of medical and pharmaceutical data and providing insights into that data; platform as a service (PAAS) featuring artificial intelligence for use in computer vision model development; platform as a service (PAAS) featuring artificial intelligence for self-service data analysis processing in the field of medicine and pharmacology.